Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Land & Improvements (2023 - 2025)

Historic Land & Improvements for Icu Medical (ICUI) over the last 3 years, with Q3 2025 value amounting to $179.9 million.

  • Icu Medical's Land & Improvements fell 3907.41% to $179.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $179.9 million, marking a year-over-year decrease of 3907.41%. This contributed to the annual value of $177.1 million for FY2024, which is 3635.64% down from last year.
  • Icu Medical's Land & Improvements amounted to $179.9 million in Q3 2025, which was down 3907.41% from $179.0 million recorded in Q2 2025.
  • Over the past 5 years, Icu Medical's Land & Improvements peaked at $295.3 million during Q3 2024, and registered a low of $174.1 million during Q1 2025.
  • Its 3-year average for Land & Improvements is $231.7 million, with a median of $229.1 million in 2023.
  • Its Land & Improvements has fluctuated over the past 5 years, first crashed by 3635.64% in 2024, then tumbled by 3907.41% in 2025.
  • Over the past 3 years, Icu Medical's Land & Improvements (Quarter) stood at $278.3 million in 2023, then crashed by 36.36% to $177.1 million in 2024, then rose by 1.58% to $179.9 million in 2025.
  • Its Land & Improvements was $179.9 million in Q3 2025, compared to $179.0 million in Q2 2025 and $174.1 million in Q1 2025.